EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.129 | (3E,7E,14E)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraen-1-yl (2R)-3-[[[[(2R,3R,4S,5S,6S)-6-carbamoyl-3-[[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-([[3-(trifluoromethyl)phenyl]carbonyl]amino)tetrahydro-2H-pyran-2-yl]oxy]-5-hydroxy-4-([[4-(trifluoromethoxy)-3-(trifluoromethyl)phenyl]carbamoyl]amino)tetrahydro-2H-pyran-2-yl]oxy](hydroxy)phosphoryl]oxy]-2-hydroxypropanoate | - |
Aquifex aeolicus | |
2.4.1.129 | (3E,7E,14E)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraen-1-yl (2R)-3-[[[[(2R,3R,4S,5S,6S)-6-carbamoyl-3-[[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-([[3-(trifluoromethyl)phenyl]carbonyl]amino)tetrahydro-2H-pyran-2-yl]oxy]-5-hydroxy-4-([[4-(trifluoromethoxy)-3-(trifluoromethyl)phenyl]carbamoyl]amino)tetrahydro-2H-pyran-2-yl]oxy](hydroxy)phosphoryl]oxy]-2-hydroxypropanoate | - |
Enterococcus faecalis | |
2.4.1.129 | (3E,7E,14E)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraen-1-yl (2R)-3-[[[[(2R,3R,4S,5S,6S)-6-carbamoyl-3-[[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-([[3-(trifluoromethyl)phenyl]carbonyl]amino)tetrahydro-2H-pyran-2-yl]oxy]-5-hydroxy-4-([[4-(trifluoromethoxy)-3-(trifluoromethyl)phenyl]carbamoyl]amino)tetrahydro-2H-pyran-2-yl]oxy](hydroxy)phosphoryl]oxy]-2-hydroxypropanoate | - |
Escherichia coli | |
2.4.1.129 | (3E,7E,14E)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraen-1-yl (2R)-3-[[[[(2R,3R,4S,5S,6S)-6-carbamoyl-3-[[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-([[3-(trifluoromethyl)phenyl]carbonyl]amino)tetrahydro-2H-pyran-2-yl]oxy]-5-hydroxy-4-([[4-(trifluoromethoxy)-3-(trifluoromethyl)phenyl]carbamoyl]amino)tetrahydro-2H-pyran-2-yl]oxy](hydroxy)phosphoryl]oxy]-2-hydroxypropanoate | - |
Helicobacter pylori | |
2.4.1.129 | (3E,7E,14E)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraen-1-yl (2R)-3-[[[[(2R,3R,4S,5S,6S)-6-carbamoyl-3-[[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-([[3-(trifluoromethyl)phenyl]carbonyl]amino)tetrahydro-2H-pyran-2-yl]oxy]-5-hydroxy-4-([[4-(trifluoromethoxy)-3-(trifluoromethyl)phenyl]carbamoyl]amino)tetrahydro-2H-pyran-2-yl]oxy](hydroxy)phosphoryl]oxy]-2-hydroxypropanoate | - |
Staphylococcus aureus | |
2.4.1.129 | (3Z)-5-(4-bromophenyl)-3-[(5-nitrofuran-2-yl)methylidene]furan-2(3H)-one | - |
Aquifex aeolicus | |
2.4.1.129 | (3Z)-5-(4-bromophenyl)-3-[(5-nitrofuran-2-yl)methylidene]furan-2(3H)-one | - |
Enterococcus faecalis | |
2.4.1.129 | (3Z)-5-(4-bromophenyl)-3-[(5-nitrofuran-2-yl)methylidene]furan-2(3H)-one | - |
Escherichia coli | |
2.4.1.129 | (3Z)-5-(4-bromophenyl)-3-[(5-nitrofuran-2-yl)methylidene]furan-2(3H)-one | - |
Helicobacter pylori | |
2.4.1.129 | (3Z)-5-(4-bromophenyl)-3-[(5-nitrofuran-2-yl)methylidene]furan-2(3H)-one | - |
Staphylococcus aureus | |
2.4.1.129 | (4Z)-2,5-diphenyl-4-[2-(1,3-thiazol-2-yl)hydrazinylidene]-2,4-dihydro-3H-pyrazol-3-one | - |
Aquifex aeolicus | |
2.4.1.129 | (4Z)-2,5-diphenyl-4-[2-(1,3-thiazol-2-yl)hydrazinylidene]-2,4-dihydro-3H-pyrazol-3-one | - |
Enterococcus faecalis | |
2.4.1.129 | (4Z)-2,5-diphenyl-4-[2-(1,3-thiazol-2-yl)hydrazinylidene]-2,4-dihydro-3H-pyrazol-3-one | - |
Escherichia coli | |
2.4.1.129 | (4Z)-2,5-diphenyl-4-[2-(1,3-thiazol-2-yl)hydrazinylidene]-2,4-dihydro-3H-pyrazol-3-one | - |
Helicobacter pylori | |
2.4.1.129 | (4Z)-2,5-diphenyl-4-[2-(1,3-thiazol-2-yl)hydrazinylidene]-2,4-dihydro-3H-pyrazol-3-one | - |
Staphylococcus aureus | |
2.4.1.129 | 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid | - |
Aquifex aeolicus | |
2.4.1.129 | 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid | - |
Enterococcus faecalis | |
2.4.1.129 | 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid | - |
Escherichia coli | |
2.4.1.129 | 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid | - |
Helicobacter pylori | |
2.4.1.129 | 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid | - |
Staphylococcus aureus | |
2.4.1.129 | chlorobiphenyl desleucyl vancomycin | - |
Aquifex aeolicus | |
2.4.1.129 | chlorobiphenyl desleucyl vancomycin | - |
Enterococcus faecalis | |
2.4.1.129 | chlorobiphenyl desleucyl vancomycin | - |
Escherichia coli | |
2.4.1.129 | chlorobiphenyl desleucyl vancomycin | - |
Helicobacter pylori | |
2.4.1.129 | chlorobiphenyl desleucyl vancomycin | - |
Staphylococcus aureus | |
2.4.1.129 | chlorobiphenyl disaccharide | - |
Aquifex aeolicus | |
2.4.1.129 | chlorobiphenyl disaccharide | - |
Enterococcus faecalis | |
2.4.1.129 | chlorobiphenyl disaccharide | - |
Escherichia coli | |
2.4.1.129 | chlorobiphenyl disaccharide | - |
Helicobacter pylori | |
2.4.1.129 | chlorobiphenyl disaccharide | - |
Staphylococcus aureus | |
2.4.1.129 | chlorobiphenyl vancomycin | - |
Aquifex aeolicus | |
2.4.1.129 | chlorobiphenyl vancomycin | - |
Enterococcus faecalis | |
2.4.1.129 | chlorobiphenyl vancomycin | - |
Escherichia coli | |
2.4.1.129 | chlorobiphenyl vancomycin | - |
Helicobacter pylori | |
2.4.1.129 | chlorobiphenyl vancomycin | - |
Staphylococcus aureus | |
2.4.1.129 | moenomycin A | - |
Aquifex aeolicus | |
2.4.1.129 | moenomycin A | - |
Enterococcus faecalis | |
2.4.1.129 | moenomycin A | - |
Escherichia coli | |
2.4.1.129 | moenomycin A | - |
Helicobacter pylori | |
2.4.1.129 | moenomycin A | - |
Staphylococcus aureus | |
2.4.1.129 | moenomycin disaccharide | - |
Aquifex aeolicus | |
2.4.1.129 | moenomycin disaccharide | - |
Enterococcus faecalis | |
2.4.1.129 | moenomycin disaccharide | - |
Escherichia coli | |
2.4.1.129 | moenomycin disaccharide | - |
Helicobacter pylori | |
2.4.1.129 | moenomycin disaccharide | - |
Staphylococcus aureus | |
2.4.1.129 | moenomycin trisaccharide | - |
Aquifex aeolicus | |
2.4.1.129 | moenomycin trisaccharide | - |
Enterococcus faecalis | |
2.4.1.129 | moenomycin trisaccharide | - |
Escherichia coli | |
2.4.1.129 | moenomycin trisaccharide | - |
Helicobacter pylori | |
2.4.1.129 | moenomycin trisaccharide | - |
Staphylococcus aureus | |
2.4.1.129 | Vancomycin | - |
Aquifex aeolicus | |
2.4.1.129 | Vancomycin | - |
Enterococcus faecalis | |
2.4.1.129 | Vancomycin | - |
Escherichia coli | |
2.4.1.129 | Vancomycin | - |
Helicobacter pylori | |
2.4.1.129 | Vancomycin | - |
Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.129 | Aquifex aeolicus | - |
- |
- |
2.4.1.129 | Enterococcus faecalis | - |
- |
- |
2.4.1.129 | Escherichia coli | - |
- |
- |
2.4.1.129 | Escherichia coli BAS849 | - |
- |
- |
2.4.1.129 | Helicobacter pylori | - |
- |
- |
2.4.1.129 | Staphylococcus aureus | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.129 | additional information | while isoform PBP1a is able to convert lipid IV (heptaprenyl-tetrasaccharide) to peptidoglycan in the absence of lipid II, isoform PBP1b does not use lipid IV as substrate unless lipid II is also present | Staphylococcus aureus | ? | - |
? | |
2.4.1.129 | additional information | while isoform PBP1a is able to convert lipid IV (heptaprenyl-tetrasaccharide) to peptidoglycan in the absence of lipid II, isoform PBP1b does not use lipid IV as substrate unless lipid II is also present | Escherichia coli | ? | - |
? | |
2.4.1.129 | additional information | while isoform PBP1a is able to convert lipid IV (heptaprenyl-tetrasaccharide) to peptidoglycan in the absence of lipid II, isoform PBP1b does not use lipid IV as substrate unless lipid II is also present | Enterococcus faecalis | ? | - |
? | |
2.4.1.129 | additional information | while isoform PBP1a is able to convert lipid IV (heptaprenyl-tetrasaccharide) to peptidoglycan in the absence of lipid II, isoform PBP1b does not use lipid IV as substrate unless lipid II is also present | Helicobacter pylori | ? | - |
? | |
2.4.1.129 | additional information | while isoform PBP1a is able to convert lipid IV (heptaprenyl-tetrasaccharide) to peptidoglycan in the absence of lipid II, isoform PBP1b does not use lipid IV as substrate unless lipid II is also present | Aquifex aeolicus | ? | - |
? | |
2.4.1.129 | additional information | while isoform PBP1a is able to convert lipid IV (heptaprenyl-tetrasaccharide) to peptidoglycan in the absence of lipid II, isoform PBP1b does not use lipid IV as substrate unless lipid II is also present | Escherichia coli BAS849 | ? | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Staphylococcus aureus | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Escherichia coli | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Enterococcus faecalis | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Helicobacter pylori | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Aquifex aeolicus | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Escherichia coli BAS849 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Staphylococcus aureus | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Escherichia coli | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Enterococcus faecalis | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Helicobacter pylori | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Aquifex aeolicus | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? | |
2.4.1.129 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol + GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-(L)-meso-diaminopimelic acid-(L)-D-Ala-D-Ala)-diphosphoundecaprenol | - |
Escherichia coli BAS849 | [GlcNAc-(1-4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n+1-diphosphoundecaprenol + undecaprenyl diphosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.1.129 | class A penicillin-binding protein | - |
Escherichia coli |
2.4.1.129 | MGT | - |
Escherichia coli |
2.4.1.129 | PBP1a | isoform | Escherichia coli |
2.4.1.129 | PBP1a | isoform | Helicobacter pylori |
2.4.1.129 | PBP1a | isoform | Aquifex aeolicus |
2.4.1.129 | PBP1b | isoform | Escherichia coli |
2.4.1.129 | PBP1c | isoform | Escherichia coli |
2.4.1.129 | PBP2 | - |
Staphylococcus aureus |
2.4.1.129 | penicillin-binding protein | - |
Staphylococcus aureus |
2.4.1.129 | penicillin-binding protein | - |
Enterococcus faecalis |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.4.1.129 | 0.000006 | - |
- |
Escherichia coli | moenomycin A | |
2.4.1.129 | 0.000006 | - |
- |
Aquifex aeolicus | moenomycin A | |
2.4.1.129 | 0.000016 | - |
- |
Escherichia coli | moenomycin trisaccharide | |
2.4.1.129 | 0.000016 | - |
- |
Aquifex aeolicus | moenomycin trisaccharide | |
2.4.1.129 | 0.000033 | - |
- |
Escherichia coli | moenomycin disaccharide | |
2.4.1.129 | 0.000033 | - |
- |
Aquifex aeolicus | moenomycin disaccharide | |
2.4.1.129 | 0.00038 | - |
- |
Escherichia coli | Vancomycin | |
2.4.1.129 | 0.00038 | - |
- |
Aquifex aeolicus | Vancomycin | |
2.4.1.129 | 0.0015 | - |
- |
Escherichia coli | chlorobiphenyl vancomycin | |
2.4.1.129 | 0.0015 | - |
- |
Aquifex aeolicus | chlorobiphenyl vancomycin | |
2.4.1.129 | 0.0037 | - |
- |
Helicobacter pylori | (4Z)-2,5-diphenyl-4-[2-(1,3-thiazol-2-yl)hydrazinylidene]-2,4-dihydro-3H-pyrazol-3-one | |
2.4.1.129 | 0.00388 | - |
- |
Escherichia coli | chlorobiphenyl desleucyl vancomycin | |
2.4.1.129 | 0.00388 | - |
- |
Aquifex aeolicus | chlorobiphenyl desleucyl vancomycin | |
2.4.1.129 | 0.0093 | - |
- |
Helicobacter pylori | 4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid | |
2.4.1.129 | 0.0098 | - |
- |
Escherichia coli | (3E,7E,14E)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraen-1-yl (2R)-3-[[[[(2R,3R,4S,5S,6S)-6-carbamoyl-3-[[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-([[3-(trifluoromethyl)phenyl]carbonyl]amino)tetrahydro-2H-pyran-2-yl]oxy]-5-hydroxy-4-([[4-(trifluoromethoxy)-3-(trifluoromethyl)phenyl]carbamoyl]amino)tetrahydro-2H-pyran-2-yl]oxy](hydroxy)phosphoryl]oxy]-2-hydroxypropanoate | |
2.4.1.129 | 0.034 | - |
- |
Helicobacter pylori | (3Z)-5-(4-bromophenyl)-3-[(5-nitrofuran-2-yl)methylidene]furan-2(3H)-one |